Acerca de
Dr Farasat Kazmi is a Consultant Clinical Oncologist specialising in lung cancer, with particular expertise in advanced radiotherapy techniques including Stereotactic Ablative Radiotherapy (SABR). He treats lung cancer across all stages, from early-stage disease to locally advanced and metastatic cancer, using modern radiotherapy alongside chemotherapy, immunotherapy, and precision-targeted therapies guided by molecular profiling.
Dr Kazmi has a strong academic and research background and holds an MSc in Nanomedicine from the University of Oxford. He previously worked in the Early Phase Clinical Trials Unit at the Churchill Hospital, Oxford, where he was involved in first-in-human and novel targeted therapy studies. He is the Principal Investigator on three international lung cancer clinical trials and has played a leading role in Cochrane systematic reviews on genomic-guided cancer therapies, ensuring his clinical practice is firmly grounded in the highest-quality evidence.
He is actively involved in precision oncology, leading institutional initiatives focused on integrating molecular testing and personalised treatment strategies into routine cancer care. His work has been recognised through national and international awards, including competitive oncology research and education grants.
In addition to lung cancer, Dr Kazmi treats gynaecological cancers, including ovarian cancer, and non-melanoma skin cancers.
He is known for his clear communication, calm manner, and patient-centred approach, taking time to explain diagnoses and treatment options and supporting shared decision-making throughout the cancer journey.
Dr Kazmi has a strong academic and research background and holds an MSc in Nanomedicine from the University of Oxford. He previously worked in the Early Phase Clinical Trials Unit at the Churchill Hospital, Oxford, where he was involved in first-in-human and novel targeted therapy studies. He is the Principal Investigator on three international lung cancer clinical trials and has played a leading role in Cochrane systematic reviews on genomic-guided cancer therapies, ensuring his clinical practice is firmly grounded in the highest-quality evidence.
He is actively involved in precision oncology, leading institutional initiatives focused on integrating molecular testing and personalised treatment strategies into routine cancer care. His work has been recognised through national and international awards, including competitive oncology research and education grants.
In addition to lung cancer, Dr Kazmi treats gynaecological cancers, including ovarian cancer, and non-melanoma skin cancers.
He is known for his clear communication, calm manner, and patient-centred approach, taking time to explain diagnoses and treatment options and supporting shared decision-making throughout the cancer journey.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Farasat Kazmi
Educación y formación
-
2017–2023 MD · Medicine and Surgery
-
2023–2027 Residency · Oncología
Carrera y nombramientos
-
2027-09–2028-08 Junior consultant
Licencias y seguros
Licencias médicas
GB — Organización Médica Colegial de España (OMC)
Certificaciones del consejo
European Board of Oncología
Seguro de responsabilidad profesional:
Generali Healthcare · 1,000,000 EUR cobertura · No claims on file
Procedimientos realizados
| Procedimiento | Código | Total acumulado |
|---|---|---|
| GP consultation | 99213 | 2,383 |
| Annual physical exam | 99395 | 825 |
| Vaccination administration | 90471 | 217 |
| Minor procedure (skin) | 17110 | 230 |
Servicios y precios
| Servicio | Duración | Modalidad | Precio |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 30 min | in_clinic | 630.00 EUR |
| Minor procedure (skin) | 120 min | in_clinic | 720.00 EUR |
Consulta, equipo y en práctica
Vídeos
Investigación y publicaciones
índice h: 5 · i10: 4
-
Long-term follow-up of Oncología across GB
DOI: 10.5950/euroclin.2026.0 · PMID: 31322945 · citado por 39
-
Validation of clinical scoring in Oncología
DOI: 10.4876/euroclin.2025.1 · PMID: 36082719 · citado por 165
Conferencias invitadas
- Practical updates in Oncología European Annual Congress (Oncología) · Vienna · 2024 · invited
- Single-centre experience in Oncología National Society Meeting · Newmarket · 2023 · oral abstract
Premios y afiliaciones
Premios
- 🏆 Top-rated Oncología — Newmarket · EuroClinics Patient Choice · 2025 · regional
Membresías en sociedades
- WONCA Europe — Family Doctors — Member · Desde 2028
- national college of family doctors — Member · Desde 2028
- European Union of Medical Specialists (UEMS) — Member · Desde 2028
Artículos de este doctor
- Patient education Patient guide to Oncología
- Awareness When should you see a oncología?
Para pacientes internacionales
- Coordinador
- Patient liaison · farasat.kazmi@euroclinics.example
Ubicación
1 etiquetaReseñas de pacientes
Comparta su experiencia — ayude a otros pacientes a encontrar el médico adecuado. Escribir una reseña →
Reseñas recientes
-
★★★★★ ✓ Verificado Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verificado Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verificado Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
Especialistas similares
Ver todos →
Dr Daniel Hochhauser
Oncología · London
Mr Henry Taylor
Oncología · Maidstone
Dr Charlotte Rees
Oncología · Winchester
Professor Hany Mohamad Eldeeb
Oncología · Milton Keynes
Dr Melanie Powell
Oncología · London
Professor Jonathan Ledermann
Oncología · London
Dr. Paul Fenton
Oncología · London
Dr Mark Nathan
Oncología · London